472 related articles for article (PubMed ID: 28602360)
1. The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis.
Ntelis K; Solomou EE; Sakkas L; Liossis SN; Daoussis D
Semin Arthritis Rheum; 2017 Dec; 47(3):409-417. PubMed ID: 28602360
[TBL] [Abstract][Full Text] [Related]
2. Platelets in Systemic Sclerosis: the Missing Link Connecting Vasculopathy, Autoimmunity, and Fibrosis?
Ntelis K; Bogdanos D; Dimitroulas T; Sakkas L; Daoussis D
Curr Rheumatol Rep; 2019 Mar; 21(5):15. PubMed ID: 30830444
[TBL] [Abstract][Full Text] [Related]
3. Serotonin and systemic sclerosis. An emerging player in pathogenesis.
Sagonas I; Daoussis D
Joint Bone Spine; 2022 May; 89(3):105309. PubMed ID: 34800695
[TBL] [Abstract][Full Text] [Related]
4. The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis.
Pauling JD; O'Donnell VB; Mchugh NJ
Platelets; 2013; 24(7):503-15. PubMed ID: 22966961
[TBL] [Abstract][Full Text] [Related]
5. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
[TBL] [Abstract][Full Text] [Related]
6. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
Yoshizaki A
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
[TBL] [Abstract][Full Text] [Related]
7. An update on biomarker discovery and use in systemic sclerosis.
Matsushita T; Takehara K
Expert Rev Mol Diagn; 2017 Sep; 17(9):823-833. PubMed ID: 28730919
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of systemic sclerosis-current concept and emerging treatments.
Furue M; Mitoma C; Mitoma H; Tsuji G; Chiba T; Nakahara T; Uchi H; Kadono T
Immunol Res; 2017 Aug; 65(4):790-797. PubMed ID: 28488090
[TBL] [Abstract][Full Text] [Related]
9. Systemic sclerosis.
Asano Y
J Dermatol; 2018 Feb; 45(2):128-138. PubMed ID: 29226387
[TBL] [Abstract][Full Text] [Related]
10. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
Jimenez SA; Piera-Velazquez S
Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.
Hasegawa M; Fujimoto M; Takehara K; Sato S
J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984
[TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus and systemic sclerosis: All roads lead to platelets.
Scherlinger M; Guillotin V; Truchetet ME; Contin-Bordes C; Sisirak V; Duffau P; Lazaro E; Richez C; Blanco P
Autoimmun Rev; 2018 Jun; 17(6):625-635. PubMed ID: 29635077
[TBL] [Abstract][Full Text] [Related]
13. Early inflammatory players in cutanous fibrosis.
Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
[TBL] [Abstract][Full Text] [Related]
14. New developments in the pathogenesis of systemic sclerosis.
Sakkas LI
Autoimmunity; 2005 Mar; 38(2):113-6. PubMed ID: 16040330
[TBL] [Abstract][Full Text] [Related]
15. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
[TBL] [Abstract][Full Text] [Related]
16. The Pathogenesis of Systemic Sclerosis: The Origin of Fibrosis and Interlink with Vasculopathy and Autoimmunity.
Ko J; Noviani M; Chellamuthu VR; Albani S; Low AHL
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762589
[TBL] [Abstract][Full Text] [Related]
17. Proposition of a novel animal model of systemic sclerosis induced by type V collagen in C57BL/6 mice that reproduces fibrosis, vasculopathy and autoimmunity.
Teodoro WR; de Jesus Queiroz ZA; Dos Santos LA; Catanozi S; Dos Santos Filho A; Bueno C; Vendramini MBG; Fernezlian SM; Eher EM; Sampaio-Barros PD; Pasoto SG; Lopes FDTQS; Velosa APP; Capelozzi VL
Arthritis Res Ther; 2019 Dec; 21(1):278. PubMed ID: 31829272
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiogenesis by platelets in systemic sclerosis patients.
Hirigoyen D; Burgos PI; Mezzano V; Duran J; Barrientos M; Saez CG; Panes O; Mezzano D; Iruretagoyena M
Arthritis Res Ther; 2015 Nov; 17():332. PubMed ID: 26584613
[TBL] [Abstract][Full Text] [Related]
19. Systemic sclerosis: Is the epithelium a missing piece of the pathogenic puzzle?
Asano Y; Takahashi T; Saigusa R
J Dermatol Sci; 2019 May; 94(2):259-265. PubMed ID: 31079997
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunity in systemic sclerosis: current concepts.
Boin F; Rosen A
Curr Rheumatol Rep; 2007 May; 9(2):165-72. PubMed ID: 17502048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
